Forbes April 24, 2024
William A. Haseltine

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in brain-machine interfaces.

In 1999, I defined regenerative medicine as the collection of interventions that restore normal function to tissues and organs damaged by disease, injured by trauma, or worn by time. I include a full spectrum of chemical, gene, and protein-based medicines, cell-based therapies, and biomechanical interventions that achieve that goal.

In the mid-20th century, A.E. van Vogt wrote about the potentiality of telepathy in his work Slan. In his writing, mutations in the human germline resulted in a human derivative species capable of telepathy. Thanks to new technology, such advances in the human species may be on the brink of...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3
State Licensing Spotlight - Prescription medical device manufacturers & distributors: Regulatory considerations applicable to medical devices versus drugs
Boston Scientific to buy Sonivie for up to $540M

Share This Article